Latest Wound healing Stories
EDEN PRAIRIE, Minn., May 14, 2012 /PRNewswire/ -- Celleration, Inc., a privately-held medical device company focused on developing and commercializing therapeutic ultrasound healing technologies, announced the first patient enrollment in IN-BALANCE VLU (Inflammation, Bacteria, & Angiogenesis effects in Launching Venous Leg Ulcer healing: A Clinical Evaluation). IN-BALANCE VLU is designed to expand on the vast body of evidence on MIST Therapy® that currently includes 12...
Fibronectin plays a major role in wound healing and embryonic development. The protein, which is located in the extracellular matrix of cells, has also been linked to pathological conditions including cancer and fibrosis. During physiological processes, fibronectin fibers are believed to experience mechanical forces that strain the fibers and cause dramatic structural modifications that change their biological activity. While understanding the role of fibronectin strain events in...
MELSUNGEN, Germany and PARIS, April 24, 2012 /PRNewswire/ -- - Management of difficult-to-treat wounds Askina Calgitrol Paste is a new ionic silver-containing wound dressing which allows an optimized intimate contact between the wound area and the antimicrobial silver ions which are produced from the silver alginate matrix. It contains on average twelve milligram of ionic silver per gram of paste which is more than in most other dressings. "The paste is easy to use,...
Cells on the move reach forward with lamellipodia and filopodia, cytoplasmic sheets and rods supported by branched networks or tight bundles of actin filaments. Cells without functional lamellipodia are still highly motile but lose their ability to stay on track, report researchers at the Stowers Institute for Medical Research in the April 9, 2012, online issue of the Journal of Cell Biology. Their study provides new insight into cell motility, a complex and integrated process, which, when...
KENNESAW, Ga., March 19, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today the signing of a global distribution agreement with Systagenix, whereby Systagenix will co-market EpiFix®. The MiMedx branded and proprietary biologic implant specifically processed from amniotic tissue, EpiFix® offers a wide variety of...
Shrimp shell nanotech for wound healing and anti-aging face cream Nanoparticles containing chitosan have been shown to have effective antimicrobial activity against Staphylococcus saprophyticus and Escherichia coli. The materials could be used as a protective wound-healing material to avoid opportunistic infection as well as working to facilitate wound healing. Chitosan is a natural, non-toxic and biodegradable, polysaccharide readily obtained from chitin, the main component of the...
Researchers have combined bioactive peptides to successfully stimulate wound healing. The in vitro and in vivo study, published today in PLoS ONE, demonstrates that the combination of two peptides stimulates the growth of blood vessels and promotes re-growth of tissue. Further development of these peptides could lead to a new treatment for chronic and acute wounds. The team tested a newly-created peptide, UN3, in pre-clinical models aimed to simulate impaired wound healing as is seen in...
BOSTON, Feb. 24, 2012 /PRNewswire-USNewswire/ -- Researchers have combined bioactive peptides to successfully stimulate wound healing. The in vitro and in vivo study, published today in PLoS ONE, demonstrates that the combination of two peptides stimulates the growth of blood vessels and promotes re-growth of tissue. Further development of these peptides could lead to a new treatment for chronic and acute wounds. The team tested a newly-created peptide, UN3, in pre-clinical...
CHANDLER, Ariz., Feb. 22, 2012 /PRNewswire/ -- Vomaris Innovations, Inc., a leading regenerative medicine company focusing on wound care with bioelectric technology, has named Michael P. Nagel as its new President and Chief Executive Officer. Mr. Nagel will also join Vomaris Innovations, Inc.'s Board of Directors. Mr. Nagel brings more than 26 years of sales, marketing and management experience in the medical device industry along with a visionary leadership approach. Before joining...
Stemedica has been issued U.S. Patent #8,105,380 by the United States Patent and Trademark Office. This broad-based patent covers the combination of scaffolds with stem cells derived from ectodermal and mesenchymal tissue. These multi-stem cell products address need in the $12.5 billion wound care field. San Diego, CA (PRWEB) February 15, 2012 Stemedica Cell Technologies, Inc. (Stemedica), a leading manufacturer of adult allogeneic stem cells and stem cell factors announced that the...
